206 related articles for article (PubMed ID: 4479947)
1. Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
Nutt J; Clark F; Welch RG; Hall R
Br Med J; 1974 Dec; 4(5946):695-6. PubMed ID: 4479947
[TBL] [Abstract][Full Text] [Related]
2. The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis.
Munro DS; Dirmikis SM; Humphries H; Smith T; Broadhead GD
Br J Obstet Gynaecol; 1978 Nov; 85(11):837-43. PubMed ID: 581471
[No Abstract] [Full Text] [Related]
3. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
4. Neonatal hyperthyroidism in an infant born of an euthyroid mother.
Samuel S; Pildes RS; Lewison M; Rosenthal IM
Am J Dis Child; 1971 May; 121(5):440-3. PubMed ID: 4103882
[No Abstract] [Full Text] [Related]
5. [Etiology of hyperthyroidism].
Lemarchand-Béraud T; Vannotti A; Griessen M
Schweiz Med Wochenschr; 1967 Oct; 97(41):1342-52. PubMed ID: 5631864
[No Abstract] [Full Text] [Related]
6. Neonatal thyrotoxicosis is associated with transplacental passage of human thyroid stimulating immunoglobulin (HTSI).
Mitchell I; Shenfield G; Brash J
Arch Dis Child; 1976 Jul; 51(7):565-7. PubMed ID: 962368
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
Gharib H; Mayberry WE
Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
[No Abstract] [Full Text] [Related]
8. Letter: Placental transmission of L. A. T. S. protector.
Dirmikis SM; Munro DS; Hiller EJ; Crawford MJ; Wynne J; Purcell M
Lancet; 1974 Dec; 2(7896):1579-80. PubMed ID: 4141025
[No Abstract] [Full Text] [Related]
9. Neonatal thyrotoxicosis: a rare pediatric emergency.
Soud GG; Derovanesian J
Ann Emerg Med; 1980 Nov; 9(11):585-7. PubMed ID: 6893645
[TBL] [Abstract][Full Text] [Related]
10. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
PINCHERA A; PINCHERA MG; STANBURY JB
J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
[No Abstract] [Full Text] [Related]
11. Neonatal thyrotoxicosis with long acting thyroid stimulator-protector.
O'Hearlihy C
Ir Med J; 1977 Mar; 70(4):124-5. PubMed ID: 576864
[No Abstract] [Full Text] [Related]
12. Placental transmission of thyroid-stimulating immunoglobulins.
Dirmikis SM; Munro DS
Br Med J; 1975 Jun; 2(5972):665-6. PubMed ID: 1173561
[TBL] [Abstract][Full Text] [Related]
13. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
14. Identification of subgroups of euthyroid graves's ophthalmopathy.
Solomon DH; Chopra IJ; Chopra U; Smith FJ
N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
Kendall-Taylor P
Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444
[TBL] [Abstract][Full Text] [Related]
16. Treatment of thyrotoxicosis--the current position. I. Classification, causation and treatment.
Greig WR
Curr Med Res Opin; 1972; 1(3):144-52. PubMed ID: 4589708
[No Abstract] [Full Text] [Related]
17. Neonatal thyrotoxicosis: report of three cases involving four infants.
Hoffmann MJ; Hetzel BS; Manson J
Australas Ann Med; 1966 Aug; 15(3):262-5. PubMed ID: 4168753
[No Abstract] [Full Text] [Related]
18. [Fetal and neonatal outcomes in infants of mothers with TSH receptor antibody positivity in pregnancy].
Zuppa AA; Perrone S; Sindico P; Alighieri G; Antichi E; Carducci C; Romagnoli C
Pediatr Med Chir; 2009; 31(2):72-7. PubMed ID: 19642499
[TBL] [Abstract][Full Text] [Related]
19. Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
Werner SC; Feind CR; Aida M
N Engl J Med; 1967 Jan; 276(3):132-8. PubMed ID: 6071187
[No Abstract] [Full Text] [Related]
20. Pathogenesis of neonatal Graves' disease.
McKenzie JM; Zakarija M
J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
